Movement Disorders

Research & Education

Research

At Stanford Movement Disorders Center, research is an important component of our program.  Through research, we hope to understand more about the underlying mechanisms of disease that cause movement disorders and translate this knowledge to clinical trials and to established therapies.

Several clinical trials are underway that examine the long-term effect of DBS for Parkinson's Disease, dystonia and tremor and the effect of these therapies on underlying disease progression.  We are also involved in multicenter clinical trials, including a trial that examines the effect of potential neuroprotective agents for early Parkinson's disease, a study of efficacy of Botulinum toxin B (Myobloc) for cervical dystonia patients and a phase III study of the new medication Stalevo for Parkinson's patients.

To find out more about clinical trials.

Education

As part of a large University Medical Center, education is central to the mission and daily activity in Stanford Movement Disorders Center.  Our attending physicians train clinical fellows, residents and medical students in the clinic and the operating room and through lectures and coursework.  Many visiting neurologists and neurosurgeons come to learn several of the specialized techniques performed here, including Botulinum toxin injection techniques, Deep Brain stimulation programming, Intra-operative physiology in the awake patient and the frameless deep brain stimulation technique.

We are also interested in maintaining an active dialogue with the patient community and have held several patient oriented clinical symposiums focusing on different aspects of Parkinson's Disease, dystonia and tremor.  Recently, a generous gift from the Blume family foundation to the NIS and SMDC has allowed us to embark on several community based events on hot topics in Parkinson's Disease such as stem cell and growth factor science and treatment, functional neuroimaging, deep brain stimulation and others.

We are able to invite international leaders in each filed to give lectures and hold interactive discussions with the audience.  We are convinced that true breakthroughs in the treatment of difficult neurological diseases will advance with the help and insight from patients and their families that have first hand experience with these diseases.

Stanford Medicine Resources:

Footer Links: